ALAMEDA, Calif. & TEL AVIV, Israel--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a biotechnology company focused on the development and commercialization of cell-based therapies, announced today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results